Clinical trial registry record

AKG and Brain Health in Aging

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase 2 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated October 6, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07861867
Last registry update
October 6, 2026
Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
University of Oklahoma
Enrollment
60
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 2
Study design
RANDOMIZED · PARALLEL · BASIC SCIENCE · TRIPLE
Evidence population
Human clinical study registration
Participants
60
Population
ALL · 55 Years
Duration
2027-02-01 to 2029-08-31
Intervention
Calcium AKG; Oral placebo capsules
Comparator
Placebo
Outcomes measured
Change in neurogliovascular coupling using functional near infrared spectroscopy (fNIRS) — 24 weeks; Change in neurovascular coupling using electroencephalography (EEG) — 24 weeks; Change in Attention — 24 weeks; Change in Working Memory — 24 weeks; Change in Executive Function — 24 weeks; Change in Processing Speed — 24 weeks; Change in Episodic Memory — 24 weeks; Body composition — 24 weeks; Change in Language — 24 weeks; Self-reported cognitive function — 24 weeks; Change in blood metabolic panel markers — 24 weeks; Physical activity — 24 weeks; Sleep quality — 24 weeks; Global Rating of Change (GRC) — at final visit
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 2A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Alpha-ketoglutarate · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

alpha ketoglutarate
Read the original source →Export JSON